Skip to main content

Table 1 Characteristics of the study cohort on intensive care unit admissiona

From: Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes

 

All patients ( N = 563)

Proven IA ( n = 94)

Putative IA ( n = 203)

Colonization ( n = 266)

Age, yr

61 ± 17

60 ± 13

62 ± 16

61 ± 18

Male, n (%)

341 (61)

54 (57)

127 (63)

160 (60)

BMI, kg/m2

24 (21 to 27)

24 (21 to 26)

23 (20 to 27)

25 (22 to 28)

Underlying conditions, n (%)

   

 No underlying disease

76 (14)

4 (4)b

11 (5)b

61 (23)

 COPD

174 (31)

22 (23)#

80 (39)b

72 (27)

 Chronic heart failure

55 (10)

8 (9)

19 (9)

28 (11)

 Diabetes

92 (16)

19 (19)

33 (16)

40 (15)

 Solid tumor

58 (10)

13 (14)

21 (9)

24 (9)

 Hematologic cancer/BMT

48 (8)

15 (16)b

31 (15)b

6 (2)

 Neutropenia

40 (7)

5 (5)b

18 (9)b

3 (1)

 Radiotherapy/chemotherapy

53 (9)

12 (13)b

33 (16)b

8 (3)

 Solid organ transplant

56 (10)

19 (20)b

28 (14)b

9 (4)

 Immunosuppressive drugs

59 (11)

27 (29)b #

25 (12)b

7 (3)

 HIV

5 (1)

1 (1)

1 (1)

3 (1)

 Liver disease

40 (7)

13 (14)b

14 (7)

13 (5)

 Chronic hemodialysis

22 (4)

3 (3)

8 (4)

11 (4)

 Smoking

88 (16)

15 (16)

28 (14)

45 (17)

 Alcohol abuse

54 (10)

9 (10)

16 (8)

29 (11)

Diagnostic categories, n (%)

   

 Medical admission

392 (70)

79 (84)b,c

94 (46)b

152 (57)

 Cardiovascular

147 (26)

29 (30)

49 (24)

69 (26)

 Respiratory

222 (39)

38 (41)b,c

107 (53)b

77 (29)

 Neurological

32 (6)

3 (3)b

3 (2)b

26 (10)

 Intoxication

5 (1)

0

1 (1)

4 (2)

 Gastrointestinal

37 (7)

6 (7)

13 (6)

18 (7)

 Endocrine

18 (3)

8 (9)b

10 (5)b

0

 Post-operative

48 (9)

7 (8)

15 (7)

26 (10)

 Trauma

47 (8)

2 (2)b

3 (2)b

42 (16)

 Others

7 (1)

1 (1)

2 (1)

4 (1)

Severity scores and main diagnoses

   

 APACHE II score on admission

23 (17 to 28)

24 (18 to 28)

25 (17 to 30)

23 (17 to 28)

 Sepsis on ICU admission

222 (39)

47 (51)b

94 (46)b

81 (30)

 ARDS on ICU admission

57 (10)

24 (26)b #

21 (10)b

12 (4)

 Septic shock, n (%)

64 (11)

14 (15)b

29 (14)b

21 (8)

 Traumatic brain injury, n (%)

28 (5)

0b

1 (1)b

27 (10)

 Pneumonia, n (%)

72 (13)

15 (16)

29 (14)

28 (11)

 Other brain injuries, n (%)

23 (4)

1 (1)b

2 (1)b

20 (8)

 Acute heart failure/CABG, n (%)

39 (7)

3 (3)b

6 (3)b

30 (11)

 Pancreatitis, n (%)

7 (1)

1 (1)

1 (1)

5 (1)

 Prophylactic antifungals, n (%)

32 (6)

8 (9)b

19 (9)b

5 (2)

 Antifungal therapy, n (%)

285 (51)

78 (85)b,c

147 (72)b

60 (22)

 Duration of therapy, daysd

13 (6 to 28)

10 (4 to 24)

12 (7 to 29)

18 (9 to 28)

  1. #p < 0.05 vs. Putative IA aAPACHE, Acute Physiology and Chronic Health Evaluation; ICU, Intensive care unit; ARDS, Acute respiratory distress syndrome; BMI, Body mass index; BMT, Bone marrow transplant; CABG, Coronary artery bypass graft; COPD, Chronic obstructive pulmonary disease; IA, Invasive aspergillosis; RRT, Renal replacement therapy. b P < 0.05 versus colonization; c P < 0.05 versus putative IA. dCalculated among those patients receiving therapy.